March 10-15, 2019 — San Francisco, CA

Event: 26th International Molecular Med Tri-Con

First session topic: Evolutionary Biomarkers: New Ways to Work with Pharma Companies

Tuesday, March 12, 2019         
Moscone South Convention Center
San Francisco, CA

Time: 5:00-6:00 p.m.

Second session topic: What Should be the FDA’s Role in Oversight of LDTs? A Town Hall Discussion

Panel Moderator
Alex Vadas, Ph.D., L.E.K. Consulting


  • Girish Putcha, MD, Ph.D., CMO & Clinical Laboratory Director, Freenome
  • Alberto Gutierrez, Ph.D., Partner, NDA Partners LLC; Former Director, Office of In Vitro Diagnostics and Radiological Health, FDA
  • Brian Abbott, Global Regulatory Lead, CDx Advisor, Amgen
  • Victoria Pratt, Ph.D., FACMG, Director, Pharmacogenomics and Molecular Genetics Laboratories, Medical and Molecular Genetics, Indiana University School of Medicine; President, AMP
  • Dennis Dietzen, Ph.D., Associate Professor of Pediatrics and Pathology, Washington University, President, AACC
  • Solomon Moshkevich, General Manager, Oncology & Transplant Businesses, Natera

Wednesday, March 13, 2019 
Moscone South Convention Center
San Francisco, CA

Time: 2:00-3:00 p.m.

About Alex Vadas
Alex Vadas is a Managing Director and Partner in L.E.K. Consulting’s Biopharma & Life Sciences practice. He joined L.E.K. in 2000 and focuses on diagnostics, research tools and personalized medicine. Within those areas, Alex has worked with a range of established and emerging clients in the areas of corporate strategy, product strategy, and planning and transaction support. He received both his Bachelor of Science and his Ph.D. in chemical engineering from the University of California, Los Angeles.

Molecular Med Tri-Con
Since its debut in 1993, the annual Molecular Medicine Tri-Conference has become one of the world's leading international events in the field of drug discovery, development and diagnostics. The Tri-Conference unites an ecosystem of 3,700 innovative thinkers and thought leaders throughout biotech, pharma and academia from around the world.

About L.E.K. Consulting
L.E.K. Consulting is a global management consulting firm that uses deep industry expertise and rigorous analysis to help business leaders achieve practical results with real impact. We are uncompromising in our approach to helping clients consistently make better decisions, deliver improved business performance and create greater shareholder returns. The firm advises and supports global companies that are leaders in their industries — including the largest private- and public-sector organizations, private equity firms, and emerging entrepreneurial businesses. Founded in 1983, L.E.K. employs more than 1,400 professionals across the Americas, Asia-Pacific and Europe. For more information, go to